Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.

Pei L, Choi JH, Liu J, Lee EJ, McCarthy B, Wilson JM, Speir E, Awan F, Tae H, Arthur G, Schnabel JL, Taylor KH, Wang X, Xu D, Ding HF, Munn DH, Caldwell C, Shi H.

Epigenetics. 2012 Jun 1;7(6):567-78. doi: 10.4161/epi.20237. Epub 2012 Jun 1.

2.

Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.

Subhash S, Andersson PO, Kosalai ST, Kanduri C, Kanduri M.

Clin Epigenetics. 2016 Oct 12;8:106. eCollection 2016.

3.

Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.

Kushwaha G, Dozmorov M, Wren JD, Qiu J, Shi H, Xu D.

Hum Genomics. 2016 Jul 25;10 Suppl 2:18. doi: 10.1186/s40246-016-0071-5.

4.

Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.

Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, Bembea M, Liu TH, Heerema NA, Rassenti L, Liyanarachchi S, Davuluri R, Byrd JC, Plass C.

Cancer Res. 2004 Apr 1;64(7):2424-33.

5.

Uncovering the DNA methylome in chronic lymphocytic leukemia.

Cahill N, Rosenquist R.

Epigenetics. 2013 Feb;8(2):138-48. doi: 10.4161/epi.23439. Epub 2013 Jan 15. Review.

6.
7.

NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib.

Wolf C, Garding A, Filarsky K, Bahlo J, Robrecht S, Becker N, Zucknick M, Rouhi A, Weigel A, Claus R, Weichenhan D, Eichhorst B, Fischer K, Hallek M, Kuchenbauer F, Plass C, Döhner H, Stilgenbauer S, Lichter P, Mertens D.

Int J Cancer. 2018 Jan 15;142(2):322-333. doi: 10.1002/ijc.31057. Epub 2017 Oct 9.

PMID:
28921505
8.

Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.

Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A, Schrenk M, Kaplanov KD, Kalashnikova OB, Pötz O, Joos TO, Hoheisel JD.

BMC Cancer. 2012 Jun 6;12:213. doi: 10.1186/1471-2407-12-213.

9.

Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.

Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS.

Mol Cancer. 2013 Dec 27;12:173. doi: 10.1186/1476-4598-12-173.

10.

Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.

Chim CS, Pang R, Liang R.

J Clin Pathol. 2008 Nov;61(11):1214-9. doi: 10.1136/jcp.2008.060152. Epub 2008 Sep 2.

PMID:
18765431
11.

Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.

Kanduri M, Cahill N, Göransson H, Enström C, Ryan F, Isaksson A, Rosenquist R.

Blood. 2010 Jan 14;115(2):296-305. doi: 10.1182/blood-2009-07-232868. Epub 2009 Nov 6. Erratum in: Blood. 2014 Jan 9;123(2):300.

12.

Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.

Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch CP, Herpel E, Rehli M, Byrd JC, Wendtner CM, Plass C.

Cancer Res. 2012 Aug 1;72(15):3775-85. Epub 2012 Jun 18.

13.

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.

Kulis M, Heath S, Bibikova M, Queirós AC, Navarro A, Clot G, Martínez-Trillos A, Castellano G, Brun-Heath I, Pinyol M, Barberán-Soler S, Papasaikas P, Jares P, Beà S, Rico D, Ecker S, Rubio M, Royo R, Ho V, Klotzle B, Hernández L, Conde L, López-Guerra M, Colomer D, Villamor N, Aymerich M, Rozman M, Bayes M, Gut M, Gelpí JL, Orozco M, Fan JB, Quesada V, Puente XS, Pisano DG, Valencia A, López-Guillermo A, Gut I, López-Otín C, Campo E, Martín-Subero JI.

Nat Genet. 2012 Nov;44(11):1236-42. doi: 10.1038/ng.2443. Epub 2012 Oct 14.

PMID:
23064414
14.

Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.

Huang D, Ovcharenko I.

BMC Genomics. 2017 Mar 16;18(1):236. doi: 10.1186/s12864-017-3617-6.

15.

Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.

Motiwala T, Majumder S, Kutay H, Smith DS, Neuberg DS, Lucas DM, Byrd JC, Grever M, Jacob ST.

Clin Cancer Res. 2007 Jun 1;13(11):3174-81.

16.

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.

Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, Ryan F, Smedby KE, Juliusson G, Sundström C, Rosén A, Rosenquist R.

Leukemia. 2013 Jan;27(1):150-8. doi: 10.1038/leu.2012.245. Epub 2012 Aug 27.

PMID:
22922567
17.

Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.

Rahmatpanah FB, Carstens S, Hooshmand SI, Welsh EC, Sjahputera O, Taylor KH, Bennett LB, Shi H, Davis JW, Arthur GL, Shanafelt TD, Kay NE, Wooldridge JE, Caldwell CW.

Epigenomics. 2009 Oct;1(1):39-61. doi: 10.2217/epi.09.10.

18.

Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.

Halldórsdóttir AM, Kanduri M, Marincevic M, Mansouri L, Isaksson A, Göransson H, Axelsson T, Agarwal P, Jernberg-Wiklund H, Stamatopoulos K, Sander B, Ehrencrona H, Rosenquist R.

Am J Hematol. 2012 Apr;87(4):361-7. doi: 10.1002/ajh.23115. Epub 2012 Feb 28.

19.

CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.

Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC, Plass C.

Cancer Res. 2006 Jan 15;66(2):653-8.

20.

Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.

Schmidt-Wolf IG, Plass C, Byrd JC, Frevel K, Pietsch T, Waha A.

Anticancer Res. 2016 Sep;36(9):4515-9.

PMID:
27630290

Supplemental Content

Support Center